Walkenstein S S, Dubb J W, Randolph W C, Westlake W J, Stote R M, Intoccia A P
Gastroenterology. 1978 Feb;74(2 Pt 2):360-5.
The bioavailability of parenteral cimetidine was tested in 12 volunteers in a balanced three-way crossover study. Blood levels and urinary excretion were compared after intramuscular and intravenous injection and oral administration of 300 mg of cinetidine. The results indicated that the intramuscular and intravenous routes are virtually interchangeable for parenteral cimetidine, and that the oral liquid, although exhibiting a reduced area under the blood level curve as compared with the parenteral doses, nevertheless demonstrated equivalence with respect to the time the blood level remained above 0.5 microgram per ml. The 300-mg cimetidine tablet formulation was found in another group of 12 volunteers to be bioequivalent to a 300-mg dose of oral liquid.
在一项平衡的三交叉研究中,对12名志愿者进行了胃肠外西咪替丁生物利用度的测试。在肌肉注射、静脉注射和口服300毫克西咪替丁后,比较了血药浓度和尿排泄情况。结果表明,对于胃肠外给药的西咪替丁,肌肉注射和静脉注射途径实际上是可互换的,并且口服液虽然与胃肠外给药剂量相比血药浓度曲线下面积减小,但在血药浓度保持高于每毫升0.5微克的时间方面仍显示出等效性。在另一组12名志愿者中发现,300毫克西咪替丁片剂配方与300毫克口服液剂量具有生物等效性。